Salute e Benessere

Disposable Medical Sensors Market Size to be Worth USD 25.4 billion by 2034…

The disposable medical sensors market is experiencing robust growth, driven primarily by the increasing prevalence of chronic diseases and the need for advanced diagnostic and therapeutic tools. Chronic conditions such as diabetes, cardiovascular diseases, and respiratory disorders necessitate continuous monitoring, thereby boosting the demand for disposable sensors. The disposable medical sensors market is experiencing robust growth, driven primarily by the increasing prevalence of chronic...
PR Newswire
23/07/2024

Molecular Diagnostics Market worth $32.7 billion by 2029 driven by Increasing…

Browse in-depth TOC on "Molecular Diagnostics Market"546 - Tables55 - Figures453 - Pages Browse in-depth TOC on "Molecular Diagnostics Market" 546 - Tables 55 - Figures 453 - Pages DANAHER (US) : Leader in Molecular Diagnostics In 2023, Danaher emerged as the top player in the molecular diagnostics market. The company's established presence within the US provides a strong foundation for expansion into emerging economies, fostering a broader global footprint. Danaher also...
PR Newswire
23/07/2024

Cleanroom Technology Market worth USD 7.28 billion in 2030 - Exclusive Report by…

Get your Sample PDF: https://www.maximizemarketresearch.com/request-sample/28733/ Get your Sample PDF:https://www.maximizemarketresearch.com/request-sample/28733/ Segment Overview MMR has segmented the market based on By Type By Construction By End user Explore Comprehensive Insights Into The Global Cleanroom Technologies Market With A Detailed Sample Report:https://www.maximizemarketresearch.com/request-sample/28733/ Detailed segmentation values...
PR Newswire
23/07/2024

Sleep Apnea Devices Market worth $9.3 billion by 2029 driven by Rising…

Browse in-depth TOC on "Sleep Apnea Devices Market" Browse in-depth TOC on "Sleep Apnea Devices Market" 483 - Table 50 - Figures 366 - Pages RESMED (US): Market Leader in Sleep Apnea Devices ResMed (US) led the sleep apnea devices market in 2023, renowned for its innovative and advanced therapeutic and diagnostic devices. The company's focus on healthcare technology expertise enables it to produce accurate and efficient sleep apnea devices, securing a significant market...
PR Newswire
23/07/2024

Platelet-derived Growth Factors (PDGFs) Market to Reach US$ 478 Million by 2034…

The platelet-derived growth factors market has experienced notable growth over the past few decades, driven by advancements in biotechnology and increased research in regenerative medicine. Treatments for genetic disorders, tissue regeneration techniques, and organ replacements are just some of the areas where RM and gene therapy are already helping to shift healthcare in developed countries like U.S. from symptomatic to curative treatments that are less costly in the long term. The...
PR Newswire
23/07/2024

ViewMind Applauded by Frost & Sullivan for Revolutionizing Brain Health…

ViewMind's patented ocular digital phenotyping uses a head-mounted display and sensors to track eye movements in response to visual stimuli. It employs advanced statistical models to analyze data, detecting even minor cognitive alterations or changes in high-level motor function. The generated report provides valuable insights into the patient's cognitive condition, enabling physicians to make informed decisions. This innovative solution combines advanced testing with a user-friendly experience…
PR Newswire
23/07/2024

Emmes Group partners with Miimansa AI to accelerate adoption of Generative AI in…

The partnership will focus on creating capabilities for quickly and accurately processing vast amounts of clinical data and enabling text to text transformations such as protocol authoring and medical writing, reducing the time and cost associated with manual data handling and analysis. The partnership will focus on creating capabilities for quickly and accurately processing vast amounts of clinical data and enabling text to text transformations such as protocol authoring and medical writing,...
PR Newswire
23/07/2024

Inspire Medical Systems, Inc. Announces Countrywide Reimbursement in France

“We are thrilled to offer our clinically proven treatment option for moderate to severe OSA to patients and physicians in France,” said Tim Herbert, Chairman and Chief Executive Officer of Inspire. “Inspire therapy is backed by a strong body of evidence and years of clinical experience demonstrating the safety and efficacy of our therapy.”Inspire therapy received European Conformity Marking for commercialization in Europe in 2010. Since that time, the company's approach has been to secure...
Nasdaq GlobeNewswire
23/07/2024

uniQure Announces Closing of Sale of Manufacturing Facility to Genezen

~ uniQure maintains preferential access to industry-leading manufacturing capabilities to support its pipeline of gene therapy candidates ~ ~ Immediate reduction in cash burn, projected to save $40 million annually ~ LEXINGTON, Mass. and AMSTERDAM, July23, 2024(GLOBE NEWSWIRE) --uniQureN.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the closing of the sale of its global manufacturing...
Nasdaq GlobeNewswire
23/07/2024

Capryl Glucoside Market to Expand at 5.9% CAGR, reaching $422.7 million by 2034…

Non-ionic surfactants, called capryl glucosides, are made from renewable vegetable sources such as glucose or coconut oil. Liquid and powder products, applications such as personal care, household cleaning products, and industrial cleaning items, and key end uses of capryl glucoside. Non-ionic surfactants, called capryl glucosides, are made from renewable vegetable sources such as glucose or coconut oil. Liquid and powder products, applications such as personal care, household cleaning...
PR Newswire
23/07/2024

Nasal Polyposis Treatment Market to Reach US$ 6.8 Bn by 2034, Fueled by Rising…

The emergence of biologic therapies targeting specific inflammatory pathways involved in nasal polyposis presents significant growth opportunities. Advances in personalized medicine approaches, tailoring treatments based on genetic and molecular characteristics, are expected to enhance treatment efficacy. The emergence of biologic therapies targeting specific inflammatory pathways involved in nasal polyposis presents significant growth opportunities. Advances in personalized medicine...
PR Newswire
23/07/2024

Nasal Irrigation Market to Reach US$ 1.9 Billion by 2034, Exhibiting a CAGR of…

A notable trend is the increasing integration of nasal irrigation with digital health platforms. Smart nasal irrigation devices equipped with connectivity features are emerging, allowing users to track their usage, receive personalized recommendations, and monitor their respiratory health through mobile apps. This integration enhances user engagement and compliance, promoting regular use. A notable trend is the increasing integration of nasal irrigation with digital health platforms. Smart...
PR Newswire
23/07/2024

Linical Named Best Global CRO by Global Health & Pharma Magazine

"On behalf of Linical, we are honored to be named the Best Global CRO" stated Clareece West, President and CCO, America and Europe. "It is remarkable to see what we have achieved as we enter our 20th year of business. We have been very thoughtful as we have grown, maintaining our commitment to providing flexible clinical development solutions for pharma and biotech clients of all sizes. Much of our business is through referrals from clients, which is a testament to our reputation…
PR Newswire
23/07/2024

Diamyd Medical receives positive feedback from FDA on potential Accelerated…

"Aligning with the FDA on the pathway for Accelerated Approval for Diamyd represents a significant step towards making this treatment available to patients with type 1 diabetes," says Ulf Hannelius, CEO of Diamyd Medical. "The potential of using C-peptide as a surrogate endpoint for accelerated approval marks an important milestone. We are committed to working closely with the FDA to diligently advance on this pathway and to obtain regulatory approval as soon as possible for this…
PR Newswire
23/07/2024

Xeltis appoints Shawn Gage as Vice President of US Clinical Affairs

Paulo Neves, Chief Medical Officer, Xeltis commented: "Shawn's appointment is emblematic of Xeltis' increasing clinical presence in the US.His experience designing and implementing clinical trials means he is the perfect candidate to lead our US pivotal trial strategy following our recent IDE approval." Paulo Neves, Chief Medical Officer, Xeltis commented : "Shawn's appointment is emblematic of Xeltis' increasing clinical presence in the US.His experience designing and…
PR Newswire
23/07/2024

Long-term treatment data for lecanemab to be presented at AAIC 2024

In addition, BioArctic will present a poster of a study highlighting deficiencies in the healthcare system's ability to diagnose and treat Alzheimer's disease in the Nordic countries. The poster will be displayed by Mats Ekelund, Head of Market Access at BioArctic. In addition, BioArctic will present a poster of a study highlighting deficiencies in the healthcare system's ability to diagnose and treat Alzheimer's disease in the Nordic countries. The poster will be displayed byMats Ekelund,...
PR Newswire
23/07/2024

Casio to Release EDIFICE Commemorating TOM'S 50th Anniversary

The new EFS-S641TMS is a collaboration between TOM'S and EDIFICE, and it incorporates design elements from the legendary TOM'S KP47 Starlet racer's detailing to commemorate the TOM'S 50th anniversary. The dial and leather band loop feature the special race car's body colors of white, red, and green. The metal band loop has a tapered shape and two differently sized holes, evoking the mounting arms of the car's side mirrors. The new EFS-S641TMS is a collaboration between TOM'S and EDIFICE, and…
PR Newswire
23/07/2024

Embla Medical hf: Interim Report Q2 2024

Sveinn Sölvason, President and CEO, comments: Sveinn Sölvason, President and CEO, comments: "We delivered our highest ever quarterly sales in Q2 2024 with sales amounting toUSD 217 million. Organic growth was 6% for Q2 and local currency growth 9% with continued strong momentum in EMEA, driven by a strong performance in Prosthetics & Neuro Orthotics and Patient Care. In our Bracing & Supports business growth was more modest for the quarter. Our EBITDA margin came in strong...
PR Newswire
23/07/2024

Sanofi: Information concerning the total number of voting rights and shares –…

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of theCode de commerce(the French Commercial Code) and article 223-16 of theRèglement général de l'Autorité des Marchés Financiers(Regulation of the French stock market authority) Sanofi a Frenchsociété anonymewith a registered share capital of 2,537,214,304 € Registered office : 46, avenue de la Grande Armée - 75017 Paris - France Registered at the Paris...
Nasdaq GlobeNewswire
22/07/2024

Valinor Pharma Announces Acquisition by Grünenthal with a Total Deal Value of…

Over the last 12 months, in partnership with Apollo Care, Valinor has implemented a suite of integrated sales, analytics, patient access, and gross-to-net management solutions that have provided the basis for record prescription growth while reducing gross-to-net and operating costs. Over the last 12 months, in partnership withApollo Care, Valinor has implemented a suite of integrated sales, analytics, patient access, and gross-to-net management solutions that have provided the basis for...
PR Newswire
22/07/2024

Global Glucose Biosensor Market Size to hit $21.3 billion by 2031, growing at a…

Market Dynamics: Market Dynamics : The Global Glucose biosensor market is witnessing high growth owing to growing prevalence of diabetes across the globe. According to WHO data, around 422 million people worldwide have diabetes and it is one of the major causes of death in developing and developed nations. Furthermore, advancement in technology and growing demand for self-monitoring blood glucose devices are also fueling the market growth. Glucose biosensors offer constant monitoring of...
PR Newswire
22/07/2024

Future of Medication Adherence Packaging: Market to Achieve US$ 2 billion by…

The likelihood of this change in the industry size is moderate and will encompass the development at a CAGR of 5.2%. This forecast will elevate prospects for key players within the industry, fueling market development. The likelihood of this change in the industry size is moderate and will encompass the development at a CAGR of 5.2%. This forecast will elevate prospects for key players within the industry, fueling market development. With the rising drug addiction cases among individuals,...
PR Newswire
22/07/2024

mRNA Vaccines and Therapeutics Market to Reach US$ 85.9 billion, Garnering a…

Continuous advancements in mRNA delivery systems, lipid nanoparticle formulations, and manufacturing processes are improving efficacy, safety, and scalability, driving market growth. Initiatives to improve global health and vaccine accessibility, combined with partnerships between governments, NGOs, and pharmaceutical companies, are expanding the reach of mRNA vaccines in developing countries. Continuous advancements in mRNA delivery systems, lipid nanoparticle formulations, and manufacturing...
PR Newswire
22/07/2024

In-Vitro Colorectal Cancer Screening Test Market worth US$ 2.5 Billion at a CAGR…

The progress of the competitive landscape is estimated to encompass a decent advancement through the forecasted period. With the scope of advancement adhering to a moderate CAGR of 7.1%, the industry avails better opportunities to key players in the sector. Owing to the changing lifestyles, consumers are found to be inclined toward several ill habits. Ranging from bad food habits like overeating processed food to excessive drinking and smoking, such lifestyle changes are an...
PR Newswire
22/07/2024
Altri  Comunicati